» Articles » PMID: 20699004

Adverse Events in Total Knee Arthroplasty: Results of a Physician Independent Survey in 260 Patients

Overview
Publisher Biomed Central
Date 2010 Aug 12
PMID 20699004
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Identification of all common and potentially avoidable adverse events is crucial to further improve the quality of medical care. The intention of the current study was to evaluate a standardized physician independent survey format on adverse events in total knee arthroplasty. The protocol for reporting adverse drug events following the International Conference of Harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH) was adopted for adverse events occurring during surgical interventions.

Material And Methods: Data of a prospective sequential cohort trial introducing a clinical pathway for total knee arthroplasty was analysed. Reporting of adverse events was done by a physician independent study nurse using the modified ICH-Good Clinical Practice (GCP) format (Structure and Content of Clinical study reports - E3) in 260 patients. The adverse events were graded to their severity and their potential relation to surgical treatment.

Results: A total of 55 patients (21%) suffered from an adverse event and 16 (6%) from a serious adverse event. In 38 patients' one adverse event occurred, 12 patients showed 2 adverse events and 5 patients suffered from a combination of an adverse and a serious adverse event. A serious adverse event alone occurred in 11 patients. The incidence of adverse events (Fisher p = 0.448) and serious adverse (p = 0.126) events showed no significant difference between the two cohorts. The most common adverse events were deep vein thrombosis (8% and 5%) followed by wound healing problems (1% and 0%) and haematoma (1% and 3%). A wide range of non surgical adverse events were recorded with low incidence levels.

Conclusion: The use of the modified ICH-GCP format supports standardization of adverse event reporting. Routine assessment of adverse events by a study nurse revealed higher incidence rates of adverse events in total knee arthroplasty. We recommend the implementation of trained paramedical staff for the documentation of adverse events in routine clinical care.

Citing Articles

A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions.

Centeno C, Al-Sayegh H, Freeman M, Smith J, Murrell W, Bubnov R Int Orthop. 2016; 40(8):1755-1765.

PMID: 27026621 DOI: 10.1007/s00264-016-3162-y.


Metal hypersensitivity and metal ion levels in patients with coated or uncoated total knee arthroplasty: a randomised controlled study.

Lutzner J, Hartmann A, Dinnebier G, Spornraft-Ragaller P, Hamann C, Kirschner S Int Orthop. 2013; 37(10):1925-31.

PMID: 23860793 PMC: 3779567. DOI: 10.1007/s00264-013-2010-6.


What can we learn from patient claims? - A retrospective analysis of incidence and patterns of adverse events after orthopaedic procedures in Sweden.

Ohrn A, Elfstrom J, Tropp H, Rutberg H Patient Saf Surg. 2012; 6(1):2.

PMID: 22264241 PMC: 3271976. DOI: 10.1186/1754-9493-6-2.

References
1.
Iorio R, Robb W, Healy W, Berry D, Hozack W, Kyle R . Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J Bone Joint Surg Am. 2008; 90(7):1598-605. DOI: 10.2106/JBJS.H.00067. View

2.
Kreder H, Berry G, McMurtry I, Halman S . Arthroplasty in the octogenarian: quantifying the risks. J Arthroplasty. 2005; 20(3):289-93. DOI: 10.1016/j.arth.2004.09.024. View

3.
Bellamy N, BUCHANAN W, Goldsmith C, Campbell J, Stitt L . Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988; 15(12):1833-40. View

4.
Parvizi J, Mui A, Purtill J, Sharkey P, Hozack W, Rothman R . Total joint arthroplasty: When do fatal or near-fatal complications occur?. J Bone Joint Surg Am. 2007; 89(1):27-32. DOI: 10.2106/JBJS.E.01443. View

5.
Coffey R, Richards J, Remmert C, LeRoy S, Schoville R, Baldwin P . An introduction to critical paths. Qual Manag Health Care. 2005; 14(1):46-55. DOI: 10.1097/00019514-200501000-00006. View